StockGlow

Ceryvyn Therapeutics Limited (UKJ0.F)

Ceryvyn Therapeutics Limited, a clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States.

0.01+0.16%Healthcare
Compare UKJ0.F with
StockGlow Score
3
Bearish
BearishBullish
1 year ago-98.2%

The outlook

Ceryvyn Therapeutics Limited currently reads as bearish based on below its 50- & 200-day averages, 0% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$7.9M
52-wk high
0.32
52-wk low
0.01
50-day avg
0.06
200-day avg
0.26
Trailing P/E
—

Similar stocks

C1S.FChina Shineway Pharmaceutical Group Limited$0.89-2.75%UR8.FUroGen Pharma Ltd.$35.07+1.53%C1P.FConsun Pharmaceutical Group Limited$1.50+0.00%PBW.FPitney Bowes Inc.$15.58+2.16%2B30.FXeris Biopharma Holdings, Inc.$7.19-0.08%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy